| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $128.3M | +2.2% |
| Cost of Revenue | $41.3M | +7.9% |
| Gross Profit | $87.1M | -0.3% |
| R&D Expense | $17.0M | -5.1% |
| SG&A Expense | $28.9M | +1.8% |
| Operating Income | $19.1M | -23.3% |
| Pre-tax Income | $22.7M | -12.9% |
| Income Tax | $1.2M | -40.6% |
| Net Income | $21.5M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.1M | +20.8% |
| Short-term Investments | $40.4M | +20.8% |
| Accounts Receivable | $46.9M | +37.8% |
| Inventory | $26.1M | -7.8% |
| Current Assets | $185.5M | +17.5% |
| Total Assets | $253.0M | +16.6% |
| Current Liabilities | $21.5M | +17.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $26.1M | +106.3% |
| Capital Expenditures | $2.6M | -39.3% |
| Investing Cash Flow | -$19.1M | -175.2% |
| Financing Cash Flow | $4.8M | +120.3% |
| Free Cash Flow | $23.5M | +179.6% |
| -10.6% |
| EPS (Basic) | $0.38 | -11.6% |
| EPS (Diluted) | $0.37 | -11.9% |
| Total Liabilities |
| $33.2M |
| +4.6% |
| Stockholders' Equity | $219.8M | +18.6% |